Company News in the Life Science Industry

»

Reset 

APhA Former Board of Trustee Member Daniel Buffington named to the AMA's Current Procedural Terminology Editorial Panel

WASHINGTON, Feb. 19, 2020 /PRNewswire/ -- The American Pharmacists Association (APhA) announced that former Board of Trustee member Daniel Buffington, PharmD, MBA, will be the first pharmacist to serve as a member of the American Medical Association's Current Procedural Terminology (CPT(®))... Read more ››

By: PR Newswire Association LLC. - 19 Feb 2020

InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward

STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of... Read more ››

By: PR Newswire Association LLC. - 19 Feb 2020

The Asia Pacific cochlear implants market is expected to reach US$ 833.1 Mn in 2027 from US$ 291.6 Mn in 2018

NEW YORK, Feb. 19, 2020 /PRNewswire/ -- The Asia Pacific cochlear implants market is expected to reach US$ 833.1 Mn in 2027 from US$ 291.6 Mn in 2018. The cochlear implant market is anticipated to grow at a growth rate of 12.5% from 2019-2027.

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2020

Allen Institute Adds Former Washington Governor, Executives From JPMorgan Chase And Deloitte To Board of Directors

SEATTLE, Feb. 19, 2020 /PRNewswire/ -- The Allen Institute today announced the appointment of three new members to its Board of Directors: Margaret Anderson, Managing Director with Deloitte Consulting LLP; Phyllis J. Campbell, Chairman of the Pacific Northwest Region for JPMorgan Chase; and Gary... Read more ››

By: PR Newswire Association LLC. - 19 Feb 2020
Related companies:  ALLEN INSTITUTE FOR BRAIN SCIENCE

Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019

SAN FRANCISCO, Feb. 19, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and full year ended December 31, 2019.

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2020
Related companies:  Invitae Corporation

Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain

SAN DIEGO, Feb. 19, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S.... Read more ››

By: PR Newswire Association LLC. - 19 Feb 2020
Related companies:  Heron Therapeutics, Inc.

REGENXBIO To Host Conference Call on February 26 to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Operational Highlights

ROCKVILLE, Md., Feb. 19, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV(®) Technology Platform, today announced that it will host a conference... Read more ››

By: PR Newswire Association LLC. - 19 Feb 2020
Related companies:  REGENXBIO Inc.

Antibacterial Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Antibacterial Drugs Market - Scope of the Study

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2020

Anticancer Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

NEW YORK, Feb. 19, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2020

2020 Pipeline Insight into Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non-Small Cell Lung Cancer

DUBLIN, Feb. 19, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 19 Feb 2020

Hysteroscopy Systems Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

NEW YORK, Feb. 19, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Feb 2020

Bausch Health Announces It Is Seeking A Refinancing Amendment To Its Existing Credit Agreement And Conditional Redemption Of Existing Senior Secured Notes

LAVAL, Quebec, Feb. 19, 2020 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it is seeking to amend and refinance its existing credit agreement (the "Credit Agreement") in order to extend and reprice its existing term loan facility... Read more ››

By: PR Newswire Association LLC. - 19 Feb 2020
Related companies:  Bausch Health Companies Inc.

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results

Read more ››
By: GlobenewsWire - 19 Feb 2020
Related companies:  Cyclacel Pharmaceuticals, Inc.

Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Tuesday, February 25, 2020

Read more ››
By: GlobenewsWire - 19 Feb 2020
Related companies:  Iovance Biotherapeutics, Inc.

Matinas BioPharma Announces DSMB Approval to Commence Part 2 of EnACT Study of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningitis

Read more ››
By: GlobenewsWire - 19 Feb 2020
Related companies:  Matinas BioPharma Holdings Inc.

Axsome Therapeutics to Present at Upcoming Investor Conferences

Read more ››
By: GlobenewsWire - 19 Feb 2020
Related companies:  Axsome Therapeutics, Inc.

Optinose Appoints Victor Clavelli as Chief Commercial Officer

Read more ››
By: GlobenewsWire - 19 Feb 2020
Related companies:  OptiNose US Inc.

Medcolcanna Signs Letters of Intent for Joint Venture and Investment into Extraction Subsidiary

Read more ››
By: GlobenewsWire - 19 Feb 2020

AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa

Read more ››
By: GlobenewsWire - 19 Feb 2020
Related companies:  Applied Genetic Technologies Corp. (AGTC)

Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma

Read more ››
By: GlobenewsWire - 19 Feb 2020
Related companies:  Molecular Templates, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Explore our database of over 50,000 companies